Frank Cappelleri of CappThesis examined some charts. He found lines going in directions. One of those directions was up. This counts as financial analysis in 2026.
The healthcare provider remains unnamed. Could be a hospital chain. Could be a medical device company. Could be a guy selling essential oils out of his garage. Doesn't matter. The technicals say it's going higher. The technicals are lines drawn by a man who gets paid whether you make money or not.
Retail traders will see this segment. They'll open their Robinhood apps at 9:31 AM. They'll buy calls. The stock will gap down 7% on earnings they didn't know were scheduled for tomorrow. They'll post rocket emojis in the daily thread while their account bleeds out like a patient in the very healthcare system they just invested in.
Cappelleri built his thesis on support levels and resistance breakouts. He identified a bull flag. He measured the Fibonacci retracement. He did everything except tell you the company's name or whether it makes money. But the chart looks pretty. The moving averages crossed. That's what matters when you're trying to fill three minutes of airtime between pharmaceutical ads.
The stock will move. That much is certain. It will go up or down or sideways. When it goes down, Cappelleri will return to explain the new technical setup. The support level became resistance. The breakout failed. Time to short it now. The charts never lie because they never actually say anything.
By next quarter, a different healthcare provider will be set up for a big move. Cappelleri will analyze those charts too. The cycle continues. The only thing moving higher with certainty is the fee structure on your managed account.
Photo by Etactics Inc on Unsplash
Leave a Comment